Slingshot members are tracking this event:

Top-Line Phase 3 Data of cabozantinib (CELESTIAL trial) for Patients with Advanced Hepatocellular Cancer (HCC) Due 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 16, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3 Data, Cabozantinib, Celestial Trial, Advanced Hepatocellular Cancer, Hcc, Top-line Data, Phase 3